Insider Activity
Six Rapport Therapeutics insiders bought $1.66 million of RAPP stock
Five directors and the CFO of Rapport Therapeutics bought RAPP shares in three sessions, while the CEO and COO sold under pre-set plans earlier this month.
TAG
biotech